JUNSHI BIO (01877) completes issuance of 300 million yuan technology innovation bonds.
Kingmed Diagnostics (01877) announced that the company has recently completed the issuance of the second tranche of technology innovation bonds for the year 2026, with the funds raised being received on July 22, 2026. The total amount raised for the second tranche of technology innovation bonds for the year 2026 is 300 million RMB, with a maturity of 3 years and due on July 22, 2029, and an issuance interest rate of 2.59%.
JUNSHI BIO (01877) announced that the company has recently completed the issuance of the second tranche of technology innovation bonds for the year 2026, with funds raised credited to their account on July 22, 2026. The total amount raised for the second tranche of technology innovation bonds for the year 2026 is RMB 300 million, with a maturity period of 3 years and set to expire on July 22, 2029. The issued interest rate is 2.59%.
Related Articles
MEDBOT-B (02252) announces profit growth, with an expected mid-term net profit of approximately 28 to 40 million RMB, turning losses into profits year-on-year.
DL HOLDINGS GP (01709) spent HK$498,000 on July 22nd to repurchase 500,000 shares.
A-shares evening hot spots | Another batch of companies unveil their earnings! A-share stock king's net profit in the first half of the year increased by more than 9 times.
MEDBOT-B (02252) announces profit growth, with an expected mid-term net profit of approximately 28 to 40 million RMB, turning losses into profits year-on-year.
DL HOLDINGS GP (01709) spent HK$498,000 on July 22nd to repurchase 500,000 shares.
A-shares evening hot spots | Another batch of companies unveil their earnings! A-share stock king's net profit in the first half of the year increased by more than 9 times.
RECOMMEND
